29 pending office actions • 15 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19329423 | Untitled | Ohio State Innovation Foundation | COFFA, SERGIO | 1658 | Non-Final OA | |
| 19179878 | Untitled | Avilar Therapeutics, Inc. | GALSTER, SAMUEL LEONARD | 1693 | Non-Final OA | |
| 19350774 | Untitled | Atea Pharmaceuticals, Inc. | LEWIS, PATRICK T | 1691 | Non-Final OA | |
| 19410698 | Untitled | Topikos Scientific, Inc. | VALENROD, YEVGENY | 1628 | Non-Final OA | |
| 19329440 | Untitled | Ohio State Innovation Foundation | REYNOLDS, FRED H | 1658 | Non-Final OA | |
| 19329410 | Untitled | Ohio State Innovation Foundation | HELLMAN, KRISTINA M | 1654 | Non-Final OA | |
| 19401124 | Untitled | Accure Therapeutics, S.L. | ROZOF, TIMOTHY R | 1625 | Non-Final OA | |
| 19329358 | CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF | Ohio State Innovation Foundation | KATAKAM, SUDHAKAR | 1658 | Non-Final OA | Sep 15, 2025 |
| 19329427 | CYCLIC CELL-PENETRATING PEPTIDE COMPOUNDS | Ohio State Innovation Foundation | COFFA, SERGIO | 1658 | Non-Final OA | Sep 15, 2025 |
| 19329417 | CELL-PENETRATING PEPTIDE COMPOUNDS | Ohio State Innovation Foundation | DABKOWSKI, ERINNE R | 1654 | Non-Final OA | Sep 15, 2025 |
| 19313605 | TOPICAL OCULAR DELIVERY OF CROMAKALIM | Mayo Foundation for Medical Education and Research | RAMOS LEWIS, JOSMALEN MILAGROS | 1621 | Non-Final OA | Aug 28, 2025 |
| 19081912 | POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS | Avilar Therapeutics, Inc. | SIMMONS, CHRIS E | 1622 | Non-Final OA | Mar 17, 2025 |
| 18936782 | HALIDE-FREE AMMONIUM SILANES | Topikos Scientific, Inc. | VALENROD, YEVGENY | 1628 | Non-Final OA | Nov 04, 2024 |
| 18917928 | METHOD OF TREATING DIABETIC MACULAR EDEMA | Oculis Operations Sàrl | HUANG, GIGI GEORGIANA | 1613 | Final Rejection | Oct 16, 2024 |
| 18739149 | NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS | Atea Pharmaceuticals, Inc. | MCINTOSH III, TRAVISS C | 1693 | Final Rejection | Jun 10, 2024 |
| 18540608 | ADVANTAGEOUS ANTI-HCV COMBINATION THERAPY | Atea Pharmaceuticals, Inc. | LEWIS, PATRICK T | 1691 | Non-Final OA | Dec 14, 2023 |
| 18503027 | Anhydrous Sodium Thiosulfate and Formulations Thereof | Fennec Pharmaceuticals Inc. | GEMBEH, SHIRLEY V | 1615 | Non-Final OA | Nov 06, 2023 |
| 18375162 | ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF | Fennec Pharmaceuticals Inc. | KWON, JOHN SEUNGJAI | 1615 | Non-Final OA | Sep 29, 2023 |
| 18236836 | METHOD FOR REDUCING OTOTOXICITY IN PEDIATRIC PATIENTS RECEIVING PLATINUM-BASED CHEMOTHERAPY | The United States Department of Veterans Affairs | HOWELL, THEODORE R | 1628 | Non-Final OA | Aug 22, 2023 |
| 18231091 | TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY | Pharmacosmos Holding A/S | CRAIGO, BAHAR ALAWI | 1699 | Non-Final OA | Aug 07, 2023 |
| 18343437 | Treatment for Intraocular Pressure Related Disorders | Mayo Foundation for Medical Education and Research | MOLOYE, TITILAYO | 1632 | Non-Final OA | Jun 28, 2023 |
| 18210991 | NEW ARYL-PYRIDO-PYRIMIDIN-ONE DERIVATIVES | Hoffmann-La Roche, Inc. | LEE, CHIHYI NMN | 1628 | Non-Final OA | Jun 16, 2023 |
| 18195296 | Method for Reducing Ototoxicity in Pediatric Patients Receiving Plantinum-Based Chemotherapy | The United States Department of Veterans Affairs | HOWELL, THEODORE R | 1628 | Non-Final OA | May 09, 2023 |
| 18111316 | STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. | PIHONAK, SARAH | 1627 | Non-Final OA | Feb 17, 2023 |
| 17983098 | TREATMENT OF METABOLIC DISORDERS THROUGH THE TARGETING OF A NOVEL CIRCULATING HORMONE COMPLEX | The President and Fellows of Harvard College | GERIDO, DWAN A | 1797 | Non-Final OA | Nov 08, 2022 |
| 17971318 | STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. | WILLIS, DOUGLAS M | 1624 | Non-Final OA | Oct 21, 2022 |
| 17890130 | HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS | Pharmacosmos Holding A/S | CORNET, JEAN P | 1628 | Non-Final OA | Aug 17, 2022 |
| 17718052 | TARGETED TREATMENT OF CANCERS WITH DYSREGULATED FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING | Pharmacosmos Holding A/S | BELL, SARA ELIZABETH | 1625 | Non-Final OA | Apr 11, 2022 |
| 17622660 | COMBINATION THERAPY METHODS, COMPOSITIONS AND KITS | Fundació De Recerca Clínic Barcelona-Institut D’Investigacions Biomèdiques August Pi I Sunyer | D' AMBROSIO, THEA | 1654 | Final Rejection | Dec 23, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial